medicines

Billionaire investor and the CEO of Pershing Square, Bill Ackman, flagged the contribution of various subsidies to the mounting U.S. debt and appreciated President Donald Trump for proposing an order to cut the drug prices, quoting his earlier suggestion. What Happened: In an X post, Ackman...

The Nasdaq Composite got hammered Tuesday. The Russell was also slammed pretty hard. The Russell, in particular, broke a key trendline of support, which implies more selling to come. And if you’ve been in the market this year then Tuesday's price action reminds you of March and April...

On Wednesday afternoon, Rite Aid (NYSE: RAD) presented a nice swing-trading opportunity with an excellent set-up. Consumer staples stocks pulled back a bit through June, offering good entry points to get into some up-trending stocks. RAD has followed suit, and looks like a no-brainer buy at...

When it comes to buying stocks, everyone wants to pick a winner. But when investors are faced with two very similar stocks for competing companies in the same market it can be challenging to choose the best one. The drug store market has seen several companies perform well on Wall Street but...